Cutler Group LLC / CA - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$66,000
-12.0%
5,837
-32.9%
0.00%
-20.0%
Q2 2022$75,000
-32.4%
8,700
+383.3%
0.01%
+25.0%
Q4 2021$111,000
+5.7%
1,8000.0%0.00%0.0%
Q3 2021$105,000
-24.5%
1,8000.0%0.00%
-33.3%
Q2 2021$139,000
+23.0%
1,8000.0%0.01%
+20.0%
Q1 2021$113,000
-75.1%
1,800
-80.0%
0.01%
-76.2%
Q4 2020$454,000
+150.8%
9,000
+25.0%
0.02%
+90.9%
Q3 2020$181,000
+26.6%
7,200
+16.1%
0.01%
+10.0%
Q2 2020$143,000
+62.5%
6,200
+6.9%
0.01%
+150.0%
Q1 2020$88,000
-33.8%
5,800
-68.0%
0.00%
-50.0%
Q4 2019$133,000
+125.4%
18,108
+94.7%
0.01%
+60.0%
Q3 2019$59,000
+742.9%
9,300
+386.9%
0.01%
Q4 2017$7,000
+16.7%
1,910
-5.0%
0.00%
Q3 2017$6,0000.0%2,010
-4.7%
0.00%
Q2 2017$6,000
-94.8%
2,110
-96.6%
0.00%
-100.0%
Q1 2017$116,000
+28.9%
62,038
-0.5%
0.01%
+66.7%
Q4 2016$90,000
-86.3%
62,338
-42.7%
0.00%
-89.7%
Q3 2016$655,000
+39.1%
108,728
+20.6%
0.03%
+20.8%
Q2 2016$471,00090,1200.02%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders